This WHO policy document outlines the importance of pharmacovigilance systems in monitoring adverse drug reactions to ensure patient safety and rational use.
Contraceptive Supplies
Maternal Health Supplies
Safe Abortion Supplies
Publication Date:
2004
This WHO policy document outlines the importance of pharmacovigilance systems in monitoring adverse drug reactions to ensure patient safety and rational use.
Share Article
Browse the full Publication Library — filter by impact area, resource type, year and collection to find what you need.